- GM Held Talks With Ford Before Turning to Chrysler
- Markets to Fall 20% More at Most: IMF Economist
- G.M. and Chrysler Explore Merger
- Stock Market Crisis: Nation's Mayors Sound Off
- US Banks Keep Pressure on SEC to Deal With Shorts
- Financial Crisis Has Inflationary And Deflationary Potential
- What the Pros Say: Swap Jitters, Bottom Searches
- Viacom Warns of Third-Quarter Profit Shortfall
- US Consumers Lose Faith in Fed Due to Crisis
- Bowyer: Mark To Market Still Lives (Unfortunately)
- Mad Mail: Why Not Shut the Market Down?
- Lightning Round OT: AFLAC, Valero and More
- Lightning Round: Chesapeake, Corning, J&J and More
- Cramer: What’s the Worst-Case Scenario?
- Game Plan: The Crash of '87 Scenario
- Cramer’s Double Secret Borrow-Binge Plan
- Your First Move For Monday October 13th
- History In The Making
Text Size 
Walgreen, one of the largest U.S. drugstore operators, said that June sales at stores open at least one year rose 3.4 percent, led by general merchandise purchases.
Walgreen's [WAG
Loading...
()
] pharmacy same-store sales rose 3.3 percent in June, while same-store sales for general merchandise, known as front-end sales, rose 3.5 percent. The shift of allergy medicine Zyrtec to over-the-counter status helped front-end sales and cut into the number of prescriptions sold.
Generic drug introductions in the past 12 months cut pharmacy same-store sales by 2.1 percentage points, the company said. Generic drugs cost less, lowering sales figures, but are more profitable for drugstores.
Total prescriptions filled at comparable stores rose 0.8 percent in the month.
Pharmacy sales accounted for 65.4 percent of total sales in the month. Total sales in June rose 9.9 percent to $4.81 billion, Walgreen said.
Print
Email
Del.icio.us
Digg It
Data is a real-time snapshot *Data is delayed at least 15 minutes